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surgical and conservative treatment are lacking. Before surgery can be undertaken, it is necessary to determine whether the overproduction is unilateral or bilateral.
An adrenal tumor found on CT images of patients with ACS may not necessarily be the source of the hypercortisolism. Studies of primary aldosteronism have demonstrated that lateralization of autonomous aldosterone production does not always correspond to findings on imaging (4) (5) (6) . Thus, for these patients, adrenal venous sampling (AVS) is the recommended preoperative procedure to distinguish between unilateral and bilateral adrenal disease (7) . Whether this also applies for ACS has not been systematically evaluated, but results from a few small studies suggest that AVS might be a valuable tool for treatment decisions (8, 9) .
When AVS is used in the evaluation of primary aldosteronism, the assessment of correct catheter position is ascertained by comparing cortisol levels in blood samples obtained from adrenal and peripheral veins. This approach is not feasible in the assessment of hypercortisolism, because cortisol is the target hormone. A promising candidate is metanephrine, which, due to its short half-life, displays a large gradient between the adrenal and peripheral veins. A recent study showed that a ratio .12 of metanephrine in the adrenal veins to that in the periphery indicated successful catheterization (10) . In addition, metanephrine is mainly excreted from the adrenal gland, and ,10% is converted from epinephrine in the bloodstream. Metanephrine levels are not significantly influenced by stress in the setting of AVS (10) .
Cholesterol scintigraphy is a nuclear radiological modality that was commonly applied to evaluate cortisol secretion from adrenal tumors (11) (12) (13) (14) (15) . Adrenal uptake of I 131 -cholesterol is determined in both adrenal glands and evaluated for dominancy and suppression over #7 days. The procedure is not in widespread use anymore owing to costs and limited availability of the imaging agent. However, as a functional imaging technique, cholesterol scintigraphy could add valuable information about lateralization, because it represents a fundamentally different strategy than morphological imaging (CT or MR) to uncover lateralization.
To our knowledge, there are only case reports about the combination of AVS and scintigraphy in the setting of ACS (16, 17) . Here, we aimed to determine whether AVS offers valuable information on lateralization compared with CT and cholesterol scintigraphy, and to what extent adrenalectomy based on AVS results cured cortisol hypersecretion.
Subjects and Methods

Subjects and study design
From January 2015 to December 2017, we consecutively included patients in whom adrenal tumors (both unilateral and bilateral) and ACS had been diagnosed at our tertiary endocrine specialist center. ACS was defined as a cortisol level .50 nmol/L after a 1-mg overnight dexamethasone suppression test (DST), and a simultaneous basal morning ACTH ,2.5 pmol/L, according to the recent European Society for Endocrinology and European Network for the Study of Adrenal Tumors guidelines (3). Low dexamethasone bioavailability as a cause of falsepositive DST was excluded by the measurement of serum dexamethasone (18) . None of the patients used oral estrogens. Altogether, 39 patients were included, of whom 37 had ACS and two overt adrenal CS. Patient characteristics are listed in Table 1 .
All study patients underwent AVS after overnight fasting. A 1-mg dose of dexamethasone was given at 11:00 PM the night before the procedure to reduce ACTH-induced fluctuations in cortisol levels. The procedure was performed by a trained radiologist between 8:00 AM and 10:00 AM, with the patient supine. The physician performed sequential catheterization of the adrenal veins by percutaneous access via the femoral vein. Correct catheter position was confirmed by the injection of small amounts of contrast fluid documented by radiograph. Samples from the external iliac vein (peripheral vein) were taken simultaneously with samples from each of the adrenal veins.
Interpretation of the AVS results
Correct adrenal vein position was ascertained by the ratio of metanephrine in the adrenal vein to that in the femoral vein. A ratio .12 was considered a representative sample (10) . The lateralization ratio was calculated by the ratio of cortisol in the two adrenal veins. A gradient .2.3 (highest to lowest concentration) was considered proof of lateralization, whereas a gradient ,2.0 was considered bilateral overproduction. Gradients between 2.0 and 2.3 represented a gray zone (8) . Most often, one sample from each location was obtained during the procedure. If the radiologist was in doubt about the catheter position, up to three samples were collected. The Based on the AVS results, the patients in the study were categorized as having bilateral or unilateral overproduction (Fig. 1) . The latter group was subdivided into patients with and without suppression of the contralateral adrenal gland. The AVS results were compared with findings on CT scans and cholesterol scintigraphy. Adrenalectomy was offered to all patients with AVS-verified unilateral overproduction. Also, patients with AVS-verified bilateral cortisol secretion were offered adrenalectomy if their metabolic burden due to ACS was high. In cases with unilateral tumors, that adrenal gland was removed. If bilateral tumors were visible, the larger adrenal gland was removed.
Postoperatively, 12.5 mg of cortisone acetate was given twice daily. Cortisone replacement was discontinued if serum cortisol concentration was .300 nmol/L in a morning sample or .485 nmol/L 60 minutes after cosyntropin stimulation (19) . This was evaluated every third month as long as cortisone was needed. All patients were followed twice a year with repeated biochemical testing and clinical evaluation. The median (range) follow-up time was 12 (3 to 24) months.
Assay of adrenal hormones
Serum cortisol and dexamethasone concentrations were assayed using an in-house-developed high-performance liquid chromatography-tandem mass spectrometry assay, as previously described in detail (20) . Metanephrine was measured by radioimmunoassay (Labor Diagnostica Nord, Nordhorn, Germany). The lower quantification limits were 0.33 nmol/L, with in-serial coefficients of variation (CVs) of 10.8% at 0.14 nmol/L and 14.5% at 3.04 nmol/L. ACTH level was assayed by chemiluminescent immunoassay (Immulite 2000 xpi; Siemens Healthineers, Erlangen, Germany). The lower limit of quantification for ACTH was 1.1 pmol/L; the reference range for a sample drawn between 8:00 AM and 10:00 AM was 2 to 11.6 pmol/L. ACTH had a total CV of 5% at 3 pmol/L and 8.4% at 49 pmol/L. All hormone analyses were performed at the Hormone Laboratory at Haukeland University Hospital.
Cholesterol scintigraphy
Corticoadrenal scintigraphy was performed with 37 MBq
Gif-sur-Yvette, France) under thyroid blockade with iodide, without administration of dexamethasone or laxatives. At 3, 5, and 7 days after IV injection of the tracer, static planar images (10 minutes per view) of the adrenal region were acquired anteriorly and posteriorly (21) . In addition, single-photon emission CT (SPECT) was performed on day 5 (128 projections, 20 seconds per view, 2 scatter windows) with coregistered, low-dose CT for attenuation correction and anatomic correlation on a Siemens Symbia T6 (Siemens Medical, Erlangen, Germany) using highenergy parallel-hole collimators. All images were analyzed visually in random order by a board-certified nuclear physician (M.B.) blinded to all clinical information. In addition, SPECT/CT images were analyzed semiquantitatively by measuring total counts in volumes of interest around each adrenal gland, using a threshold of 50% of maximum counts per voxel on the Oasis image processing system (version 1.9.4.9; Segami, Columbus, MD). A cutoff for lateralization of 3 for the ratio of absolute counts in the dominant adrenal gland to those in the nondominant adrenal gland was determined on the basis of receiver operating characteristic (ROC) analysis. All images were categorized as having symmetric uptake or lateralization; those in the latter group also were categorized as having contralateral suppression of the nondominant adrenal gland or not (Supplemental Methods).
Statistical analyses
The patients' characteristics are reported as median (range). ROC curves were https://academic.oup.com/jcemused for computing the sensitivity, specificity, and the cutoff for lateralization on SPECT/CT images. The Mann Whitney U test was used to compare groups.
Ethics
The study was approved by the local ethics committee and all participants signed the informed consent form (ClinicalTrials.gov no. 02543697).
Results
Patient characteristics
A total of 39 patients with diagnosed ACS underwent AVS (Table 1) . Their median age was 66 (40 to 80) years. Women were overrepresented (77%), and we found a high proportion of hypertension, impaired glucose tolerance and diabetes mellitus, and osteoporosis. The serum cortisol level after 1-mg overnight DST varied from 59 to 692 nmol/L. The median size of the adrenal tumors was 33 (range, 21 to 40) mm; that of unilateral and bilateral tumors was 27 mm ((range, 15 to 60) mm and 37 mm (range, 20 to 60) mm, respectively.
The AVS procedure and lateralization
The AVS procedure was successful in 34 patients, and successful at the first attempt in 33 (success rate, 85%). The AVS procedure was repeated for two patients with unsuccessful catheterization; the repeated procedure was successful in one of those two. All unsuccessful procedures were due to inability to cannulate the right adrenal vein. One patient was retested to verify the findings before the operation-both times successfully. When several blood samples were taken from the same anatomical site, the fluctuation in cortisol concentrations were 4.7% (range, 0% to 26%). There was not a significant difference between the right and the left sides. One patient experienced abdominal pain or discomfort during the procedure, but CT imaging 4 hours afterward did not reveal any bleeding. No explanation for the discomfort was found, and the patient was observed an additional day. No other complications were noted related to the procedure.
Of the 34 patients with successful AVS, 2 had overt adrenal CS and 32 had ACS. Twenty patients had unilateral tumors on CT scan (12 on the left side, eight on the right side), of whom 11 had AVS suggesting lateralization to the side of the tumor, whereas nine had bilateral cortisol production. There was no significant difference in degree of AVS lateralization between left-and rightside tumors. Fourteen patients had bilateral adrenal tumors on CT scan; AVS showed bilateral overproduction in 10 and unilateral production in four. If we consider AVS as the gold standard, these results translate to a sensitivity of 73% and a specificity of 45% for lateralization of cortisol secretion, if a unilateral tumor is found on CT imaging. The results are summarized in Table 2 .
Of the 15 patients with lateralization according to AVS, five also had contralateral suppression of cortisol secretion. Of these, three had suppressed plasma ACTH ,1.1 pmol/L in the basal blood sample, and the remaining two patients had low but detectable ACTH levels at 1.4 and 1.9 pmol/L. The ratios of cortisol in the nondominant adrenal vein to that in the peripheral vein in these five patients were 1.19, 1.21, 1.25, 1.36, and 1.67.
In the 10 patients with lateralization on AVS but no contralateral suppression, basal plasma ACTH level was suppressed in two, and varied between 1.2 and 2.0 pmol/L in the other eight. We found no significant difference between cortisol suppression after DST between patients who had lateralization on AVS and those who did not. If we redefined the cortisol/cortisol gradient between dominant and nondominant side to 2.0 as lateralization, one patient with bilateral tumors was recategorized on AVS to unilateral overproduction. For the 20 patients with unilateral tumor on CT imaging, the results did not differ whether a ratio of 2.3 or 2.0 was used. The patient who had two successful procedures had the same AVS result both times, with bilateral overproduction of cortisol and a cortisol gradient between the left and right adrenal veins of 1.1.
Scintigraphy compared with AVS and CT
Cholesterol scintigraphy was performed in 22 patients. The quantitative evaluations of the SPECT and CT images from day 5 best matched our AVS findings. In four patients (three with unilateral tumor), only CT images were available for comparison because of failed samplings; for these four, scintigraphy findings were concordant with the CT findings. In 18 patients, CT and AVS results were available for comparison with scintigraphy findings (Supplemental Table 1 ). Scintigraphy results were concordant with AVS findings in 13 of the 18 patients (72%; Fig. 2) . Of the five patients with nonconcordant results, two had lateralization on scintigraphy but bilateral overproduction on AVS. The opposite was found in the other three patients: bilateral uptake on scintigraphy and lateralization on AVS. Laterality actually was found on visual interpretation of scintigraphy in the latter three patients, but the lateralization criteria were not fulfilled on quantitative analysis of SPECT/CT images. Furthermore, as shown in Table 3 , scintigraphy was always concordant with CT in cases with bilateral tumors (six of six cases) as opposed to the unilateral tumors, of which only 10 of 16 had unilateral scintigraphy uptake.
If we consider AVS as the gold standard, ROC analyses revealed an area under the curve of 0.74 when using the ratio of total counts in each adrenal gland on SPECT for quantitative analysis. Assuming a cutoff ratio .3 of total counts in the dominant to total counts in the nondominant adrenal gland, the sensitivity for quantitative analysis was 57%, and specificity 73%, whereas results on visual analysis planar imaging were markedly inferior (Supplemental Table 1 ).
Results of follow-up
All patients with lateralization on AVS were offered adrenalectomy. Seven accepted and eight declined. Five patients with bilateral cortisol production on AVS also underwent adrenalectomy, because of the symptom burden of their ACS. When unilateral tumor was found on CT (n = 3), this adrenal gland was removed. With bilateral CT findings, the larger adrenal gland was extirpated. In total, 12 patients underwent unilateral adrenalectomy (Fig. 1) . Nine of these patients were treated with cortisone acetate postoperatively; in six, this treatment could be discontinued after a median 3.5 (range, 1 to 24) months. Three patients are still receiving cortisone acetate treatment 6, 9, and 12 months after their operation. All but one patient who underwent adrenalectomy had a normalized morning plasma ACTH level at the first postoperative measurement (i.e., .2.5 nmol/L). Eight of the nine patients who are no longer receiving cortisone substitution have a serum cortisol value ,50 nmol/L after DST. The patient with DST .50 nmol/L also had a suppressed basal plasma ACTH level. Thus, 11 of 12 patients who underwent adrenalectomy were cured.
Twenty-seven patients were treated conservatively. One of these had a normalization of ACTH and serum cortisol concentrations after overnight DST at one point during the total follow-up period of 24 months. She had unilateral secretion of cortisol according to AVS and scintigraphy, with a suppressed contralateral adrenal gland, suggesting that the diagnosis of ACS was correct. Seven of the 27 patients who did not undergo surgery had one or more measurements of plasma ACTH .2.5 (range, 2.6 to 6.7) pmol/L during the 24-month follow-up period, but they had DST with serum cortisol levels .50 nmol/L at all test points.
Discussion
In this study, we demonstrated that AVS is feasible in ACS and yields important information that can determine the treatment. We demonstrated several cases with bilateral tumors and AVS-confirmed unilateral secretion, and vice versa. Thus, AVS provides necessary and sufficient information if unilateral adrenalectomy is considered. The procedure is rapid, has a high success rate, and few complications. The AVS results are often, but not always, concordant with those of cholesterol scintigraphy, which was previously considered the gold standard for evaluation of cortisol secretion from the adrenal glands (Fig. 3) .
Moreover, in our study, almost half of the patients with unilateral tumor on CT imaging had bilateral overproduction of cortisol. This is important information because surgery is less likely to permanently cure bilateral overproduction. On the other hand, patients with bilateral tumors detected on CT imaging often are found to have bilateral cortisol hypersecretion on AVS. In some cases, however, the overproduction is clearly unilateral, enabling curative treatment by adrenalectomy. Current guidelines for adrenal incidentalomas recommend operation for ACS in patients with bilateral findings only when the patient shows clear signs of overt CS (3). If AVS results are included in the evaluation, bilateral adrenalectomy can be avoided. AVS can also enable us to offer operative treatment and cure to some patients with milder cortisol excess, which might lead to better metabolic profile and less comorbidity.
Our data indirectly suggest that ACS resembles primary aldosteronism, in that small, autonomous foci in the adrenal cortex that are not visible on CT imaging could be responsible for cortisol hypersecretion. Also, in some cases of bilateral adrenal hyperplasia, there was clear unilateral overproduction of cortisol on AVS, and these patients, therefore, might benefit from adrenalectomy.
Our results indicate that unilateral overproduction of cortisol does not necessarily lead to contralateral suppression of cortisol secretion. In cases without suppression of ACTH, this is not unexpected; in cases with suppressed ACTH, one would expect contralateral suppression. However, we have to keep in mind that subtle ACTH secretion can take place below the detection limit for our plasma ACTH assay (1.1 pmol/L). Furthermore, ACTH is secreted in pulses and detectable levels might be present at other times. Our results also show that one cannot infer that suppressed plasma ACTH combined with contralateral suppression on AVS or scintigraphy necessarily indicates development of postoperative adrenal insufficiency. When comparing the scintigraphy result with the AVS findings, we surprisingly found two patients with lateralization on scintigraphy and bilateral overproduction on AVS, and three patients with the opposite constellation (i.e., lateralization on AVS and bilateral overproduction on scintigraphy). A possible explanation may be that scintigraphic cholesterol uptake represents an integral of total adrenal synthesis of steroid hormones over several days, whereas selective sampling represents a spot image of cortisol production. Also, the procedures were performed on different days and under slightly different conditions. AVS is done under dexamethasone suppression and scintigraphy not, which could influence results. In situations with discordant results, no definite conclusions could be drawn, but we are inclined to place confidence in AVS. None of the four patients with contradictory results underwent surgery.
Taken together, the AVS and scintigraphy results matched quite well. The high cure rate after adrenalectomy, based mainly on AVS results, indicates that AVS could be a valuable diagnostic preoperative tool to confirm which adrenal gland should be removed.
The only patient who was not biochemically cured after surgery had bilateral tumors on CT imaging and lateralization without contralateral suppression of cortisol secretion on AVS. She underwent surgery before scintigraphy was available. It could be that her other adrenal gland was autonomous all along. She now has other serious disease, which complicates further diagnostics and follow-up for hypercortisolism.
ACS seems to fluctuate in the patients followed-up conservatively. One patient clearly had unilateral secretion of cortisol on AVS and scintigraphy, but both plasma ACTH level and DST normalized at one time point during the follow-up period. Another seven patients have had plasma ACTH-measurements .2.5 pmol/L at some point in the follow-up period but pathological DST at each test point.
AVS was performed under dexamethasone suppression to avoid stress-related fluctuations in ACTH. The need for this can be discussed, because most of these patients already had suppressed or low ACTH. However, in our view, dexamethasone suppression contributes to standardization of the procedure. On the other hand, we chose a lower dose of dexamethasone than was used in other studies, because 1 mg is enough to suppress ACTH. We do not think the different dexamethasone dose significantly altered the results, because when ACTH is suppressed, the cortisol secretion stimulated from the hypothalamic-pituitary-adrenal axis is blocked. We perform the scintigraphy without dexamethasone suppression to avoid exacerbation of hypertension, hyperglycemia, and other associated adverse effects that could be the result of week-long dexamethasone administration.
One of the strengths of this study is that AVS was compared with both cholesterol scintigraphy and CT, two fundamentally different imaging methods. This is important because both approaches have limitations and there is no consensus on how to differentiate between unilateral and bilateral hypersecretion of cortisol. Moreover, our study also adds postoperative outcome data, which further support the performance characteristics of AVS. Another strength is the substantially larger study population than in previous reports of AVS in ACS (8, 9, 22) .
The limitations of our study are that there is no control cohort with AVS in healthy subjects, but we found it unethical to let healthy volunteers go through AVS. Another limitation is that we have no biochemical marker to control for dilution from the splenic vein on the left side, or for how far from the adrenal gland the catheter is placed on each side. For primary aldosteronism, dilution is corrected for by calculations of aldosterone-to-cortisol ratios instead of absolute aldosterone levels. In our situation, a possibility would be to use cortisol-to-metanephrine ratios. Unfortunately, this was problematic due to several factors. First, metanephrines had a steeper decrease in concentration than cortisol between the adrenal and peripheral veins. Thus, the cortisol-to-metanephrine ratios were higher in the peripheral veins than in the adrenal veins, possibly due to the shorter half-life of metanephrines compared with cortisol. Second, the CV was high for metanephrine, giving a high degree of uncertainty about the actual metanephrine value for each sample. Furthermore, measurements were often below the limit of quantification in the peripheral vein and above upper limit of quantification in the adrenal veins, making ratio calculations imprecise. Also, the linearity of the assay is poor for high levels of metanephrine. Young et al. (8) estimated that the dilution from the splenic vein could be up to 20%, which must be kept in mind when interpreting the result, but that there was not significantly more lateralization from right-side tumors compared with those on the left side contradicts that a high degree of dilution takes place. Also, the definition of contralateral suppression is arbitrary and needs to be reconsidered in future studies. The cutoff is less strict than that used for hyperaldosteronism because we reasoned that there could be some variation in cortisol levels between samples. In any account, with a cutoff of 2, the contribution from the nondominant adrenal gland is very small.
In conclusion, we find that AVS is a safe and feasible method to decide if ACS is unilateral or bilateral. Also, our results show that laterality cannot be assessed solely on the basis of CT findings. The AVS results are often, but not always, concordant with results from cholesterol scintigraphy. When they are not, we believe the AVS result should be trusted for planning of further treatment.
